What is Cast21?
Founded in 2015, Cast21 is redefining patient care through the development of advanced orthopedic immobilization solutions. By utilizing a medalist thermoplastic elastomer, the company has engineered a lightweight, breathable, and waterproof alternative to traditional plaster or fiberglass casts. The firm's patent-pending tubing system allows for precise molding to the patient's anatomy, significantly enhancing comfort and hygiene during the recovery process. As a disruptor in the medical device manufacturing space, Cast21 addresses long-standing inefficiencies in musculoskeletal treatment, moving away from cumbersome, moisture-trapping materials toward a modern, patient-centric design that facilitates better clinical outcomes.
How much funding has Cast21 raised?
Cast21 has raised a total of $800K across 1 funding round:
Private Equity
$800K
Private Equity (2017): $800K with participation from MB Venture Partners, Bindley Western Industries, IllinoisVENTURES, and Innova Memphis
Key Investors in Cast21
MB Venture Partners
A Memphis-based venture capital firm specializing in life science companies and medical device innovation, with a strong track record of facilitating exits to major industry players.
IllinoisVENTURES
A venture capital firm focused on seed and Series A investments in deep tech sectors, providing critical support to early-stage innovators with strong academic and engineering foundations.
Innova Memphis
An early-stage investor dedicated to high-growth healthcare and technology startups, offering both seed capital and hands-on mentorship to drive economic impact.
What's next for Cast21?
With the recent infusion of capital, Cast21 is poised to scale its manufacturing operations and broaden its distribution network. The company's strategic roadmap focuses on deepening its penetration into the orthopedic market, leveraging its unique intellectual property to displace legacy casting methods. By prioritizing clinical adoption and operational efficiency, Cast21 aims to solidify its status as a leader in medical device innovation. Future growth will likely involve expanding its product portfolio to address a wider range of musculoskeletal injuries, supported by the continued backing of its seasoned investor syndicate, which brings deep expertise in life sciences and healthcare technology commercialization.
See full Cast21 company page
